ERBB2 and neoplasm: Based on the American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) HER2 testing guidelines [2] and earlier studies [5], it has shown that HER2-negative BCs have varying degrees of HER2 protein expression on the tumor cell membrane.